Cargando…
MicroRNA‐483 amelioration of experimental pulmonary hypertension
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), part...
Autores principales: | Zhang, Jin, He, Yangyang, Yan, Xiaosong, Chen, Shanshan, He, Ming, Lei, Yuyang, Zhang, Jiao, Gongol, Brendan, Gu, Mingxia, Miao, Yifei, Bai, Liang, Cui, Xiaopei, Wang, Xiaojian, Zhang, Yixin, Fan, Fenling, Li, Zhao, Shen, Yuan, Chou, Chih‐Hung, Huang, Hsien‐Da, Malhotra, Atul, Rabinovitch, Marlene, Jing, Zhi‐Cheng, Shyy, John Y‐J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207157/ https://www.ncbi.nlm.nih.gov/pubmed/32324970 http://dx.doi.org/10.15252/emmm.201911303 |
Ejemplares similares
-
microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production
por: Dong, Jianjie, et al.
Publicado: (2020) -
Serum miR-92a is Elevated in Children and Adults with Obstructive Sleep Apnea
por: Gongol, Brendan, et al.
Publicado: (2020) -
Role of endothelial cells in pulmonary fibrosis via SREBP2 activation
por: Martin, Marcy, et al.
Publicado: (2021) -
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
por: Li, Jinghong, et al.
Publicado: (2020) -
483. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with Hemodialysis
por: Li, Xin, et al.
Publicado: (2023)